Home/Filings/4/0001127602-18-005553
4//SEC Filing

YOUNG KEVIN 4

Accession 0001127602-18-005553

CIK 0000882095other

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 4:58 PM ET

Size

8.0 KB

Accession

0001127602-18-005553

Insider Transaction Report

Form 4
Period: 2018-02-10
YOUNG KEVIN
EVP, Commercial Operations
Transactions
  • Exercise/Conversion

    Common Stock

    2018-02-10+90816,237 total
  • Tax Payment

    Common Stock

    2018-02-10$79.32/sh425$33,71115,812 total
  • Exercise/Conversion

    Restricted Stock Unit

    2018-02-109083,184 total
    Common Stock (908 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
  • [F2]The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.

Issuer

GILEAD SCIENCES INC

CIK 0000882095

Entity typeother

Related Parties

1
  • filerCIK 0001303643

Filing Metadata

Form type
4
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 4:58 PM ET
Size
8.0 KB